2,499
Participants
Start Date
June 30, 2007
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
daily TDF/FTC
daily oral medication
Placebo
daily oral medication
Desmond Tutu HIV Ctr. iPrEx CRS, Cape Town
Research Institute for Health Sciences iPrEx CRS, Chiang Mai
Stroger Hospital of Cook County/Core Center IPREX CRS, Chicago
San Francisco Dept. of Public Health iPrEx CRS, San Francisco
Fenway Community Health iPrEx CRS, Boston
IPEC/FIOCRUZ iPrEx CRS, Rio de Janeiro
Projeto Praca Onze, Universidade Federal do Rio de Janeiro iPrEx CRS, Rio de Janeiro
Universidade de Sao Paulo iPrEx CRS, São Paulo
Fundación Ecuatoriana Equidad, Guayaquil, iPrEx CRS, Guayaquil
Asociación Civil Selva Amazónica, Iquitos, iPrEx CRS, Iquitos
Investigaciones Médicas en Salud (INMENSA), Lince, iPrEx CRS, Lima
Bill and Melinda Gates Foundation
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH